Cargando…

Validation of cytoplasmic-to-nuclear ratio of survivin as an indicator of improved prognosis in breast cancer

BACKGROUND: Conflicting data exist regarding the prognostic and predictive impact of survivin (BIRC5) in breast cancer. We previously reported survivin cytoplasmic-to-nuclear ratio (CNR) as an independent prognostic indicator in breast cancer. Here, we validate survivin CNR in a separate and extende...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rexhepaj, Elton, Jirstrom, Karin, O'Connor, Darran P, O'Brien, Sallyann L, Landberg, Goran, Duffy, Michael J, Brennan, Donal J, Gallagher, William M
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2010
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2999619/ https://www.ncbi.nlm.nih.gov/pubmed/21092276 http://dx.doi.org/10.1186/1471-2407-10-639

Ejemplares similares

Novel image analysis approach for quantifying expression of nuclear proteins assessed by immunohistochemistry: application to measurement of oestrogen and progesterone receptor levels in breast cancer
por: Rexhepaj, Elton, et al.
Publicado: (2008)

Tumour-specific HMG-CoAR is an independent predictor of recurrence free survival in epithelial ovarian cancer
por: Brennan, Donal J, et al.
Publicado: (2010)

Identification of a myometrial molecular profile for dystocic labor
por: Brennan, Donal J, et al.
Publicado: (2011)

The tumour suppressor SOX11 is associated with improved survival among high grade epithelial ovarian cancers and is regulated by reversible promoter methylation
por: Sernbo, Sandra, et al.
Publicado: (2011)

Tumor-specific HMG-CoA reductase expression in primary premenopausal breast cancer predicts response to tamoxifen
por: Brennan, Donal J, et al.
Publicado: (2011)

Expression of cytoplasmic and nuclear Survivin in primary and secondary human glioblastoma
por: Xie, D, et al.
Publicado: (2006)

Systematic antibody generation and validation via tissue microarray technology leading to identification of a novel protein prognostic panel in breast cancer
por: O´Leary, Patrick C, et al.
Publicado: (2013)

Nuclear and cytoplasmic expression of survivin in 67 surgically resected pancreatic cancer patients
por: Tonini, G, et al.
Publicado: (2005)

Nuclear and cytoplasmic expression of survivin in 67 surgically resected pancreatic cancer patients
por: Tonini, G, et al.
Publicado: (2005)

Expression of the RNA-binding protein RBM3 is associated with a favourable prognosis and cisplatin sensitivity in epithelial ovarian cancer
por: Ehlén, Åsa, et al.
Publicado: (2010)

Differential expression of cytoplasmic and stromal β-arrestin-1 is associated with separate aspects of tumor behavior in breast cancer
por: Lundgren, K, et al.
Publicado: (2009)

A novel mechanism of regulation of the anti-metastatic miR-31 by EMSY in breast cancer
por: Mulrane, Laoighse, et al.
Publicado: (2014)

Molecular correlates and prognostic significance of SATB1 expression in colorectal cancer
por: Nodin, Björn, et al.
Publicado: (2012)

Expression of survivin and its splice variants survivin-2B and survivin-ΔEx3 in breast cancer
por: Ryan, B, et al.
Publicado: (2005)

Low ERK Phosphorylation in Cancer-Associated Fibroblasts Is Associated with Tamoxifen Resistance in Pre-Menopausal Breast Cancer
por: Busch, Susann, et al.
Publicado: (2012)

Long‐term hepatic safety of lomitapide in homozygous familial hypercholesterolaemia
por: Larrey, Dominique, et al.
Publicado: (2022)

Peroxiredoxin-1 protects estrogen receptor α from oxidative stress-induced suppression and is a protein biomarker of favorable prognosis in breast cancer
por: O’Leary, Patrick C, et al.
Publicado: (2014)

Homeobox transcription factor muscle segment homeobox 2 (Msx2) correlates with good prognosis in breast cancer patients and induces apoptosis in vitro
por: Lanigan, Fiona, et al.
Publicado: (2010)

Diet and body constitution in relation to subgroups of breast cancer defined by tumour grade, proliferation and key cell cycle regulators
por: Borgquist, Signe, et al.
Publicado: (2007)

PKCα expression is a marker for breast cancer aggressiveness
por: Lønne, Gry Kalstad, et al.
Publicado: (2010)

Downregulation of miR-92a Is Associated with Aggressive Breast Cancer Features and Increased Tumour Macrophage Infiltration
por: Nilsson, Sofie, et al.
Publicado: (2012)

Subcellular analysis of nuclear and cytoplasmic redox indices differentiates breast cancer cell subtypes better than nuclear-to-cytoplasmic area ratio
por: Jacob, Annemarie, et al.
Publicado: (2022)

Prognostic significance of Daxx NCR (Nuclear/Cytoplasmic Ratio) in gastric cancer
por: Xu, Jian‐feng, et al.
Publicado: (2017)

Balance of osmotic pressures determines the nuclear-to-cytoplasmic volume ratio of the cell
por: Deviri, Dan, et al.
Publicado: (2022)

Mitotic chromosomes scale to nuclear-cytoplasmic ratio and cell size in Xenopus
por: Zhou, Coral Y, et al.
Publicado: (2023)

De novo post-diagnosis statin use, breast cancer-specific and overall mortality in women with stage I–III breast cancer
por: Smith, Amelia, et al.
Publicado: (2016)

Early diagnostic value of Bcl-3 localization in colorectal cancer
por: Saamarthy, Karunakar, et al.
Publicado: (2015)

Expression of Nuclear Factor Kappa B and Survivin in Psoriasis
por: Gunduz, Kamer, et al.
Publicado: (2012)

Decreased expression of Yes-associated protein is associated with outcome in the luminal A breast cancer subgroup and with an impaired tamoxifen response
por: Lehn, Sophie, et al.
Publicado: (2014)

Expression of survivin detected by immunohistochemistry in the cytoplasm and in the nucleus is associated with prognosis of leiomyosarcoma and synovial sarcoma patients
por: Taubert, Helge, et al.
Publicado: (2010)

Clinical correlation of nuclear survivin in esophageal squamous cell carcinoma
por: Hui, Marco K. C., et al.
Publicado: (2012)

An Essential Role of the Cytoplasmic Tail of CXCR4 in G-Protein Signaling and Organogenesis
por: Cronshaw, Darran G., et al.
Publicado: (2010)

Prognostic impact of tumour-specific HMG-CoA reductase expression in primary breast cancer
por: Borgquist, Signe, et al.
Publicado: (2008)

Detection of Survivin and COX-2 in Thyroid Carcinoma: Anaplastic Carcinoma Shows Overexpression of Nuclear Survivin and Low COX-2 Expression
por: Kim, Young A, et al.
Publicado: (2012)

Loss of cytoplasmic survivin expression is an independent predictor of poor prognosis in radically operated prostate cancer patients
por: Büscheck, Franziska, et al.
Publicado: (2020)

Prognostic value of nuclear survivin expression in oesophageal squamous cell carcinoma
por: Grabowski, P, et al.
Publicado: (2003)

Nuclear survivin as a biomarker for non-small-cell lung cancer
por: Lu, B, et al.
Publicado: (2004)

Nuclear survivin expression is associated with HPV-independent carcinogenesis and is an indicator of poor prognosis in oropharyngeal cancer
por: Preuss, S F, et al.
Publicado: (2008)

Increased androgen receptor expression in serous carcinoma of the ovary is associated with an improved survival
por: Nodin, Björn, et al.
Publicado: (2010)

High nuclear/cytoplasmic ratio of Cdk1 expression predicts poor prognosis in colorectal cancer patients
por: Sung, Wen-Wei, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_iv1gf8405cvuc8k6uhlv59e7jl